John Noviasky

655 total citations
33 papers, 414 citations indexed

About

John Noviasky is a scholar working on Geriatrics and Gerontology, Pediatrics, Perinatology and Child Health and Psychiatry and Mental health. According to data from OpenAlex, John Noviasky has authored 33 papers receiving a total of 414 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Geriatrics and Gerontology, 7 papers in Pediatrics, Perinatology and Child Health and 7 papers in Psychiatry and Mental health. Recurrent topics in John Noviasky's work include Pharmaceutical Practices and Patient Outcomes (11 papers), Pharmaceutical studies and practices (6 papers) and Intensive Care Unit Cognitive Disorders (5 papers). John Noviasky is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (11 papers), Pharmaceutical studies and practices (6 papers) and Intensive Care Unit Cognitive Disorders (5 papers). John Noviasky collaborates with scholars based in United States, Australia and Germany. John Noviasky's co-authors include Connie Holt, Christopher Cox, Pierre N. Tariot, Roy Guharoy, Anton P. Porsteinsson, Carrie Irvine, Rosemary Erb, Laura Jakimovich, Nancy Kowalski and Elizabeth F. Smith and has published in prestigious journals such as CHEST Journal, Mayo Clinic Proceedings and American Journal of Geriatric Psychiatry.

In The Last Decade

John Noviasky

31 papers receiving 388 citations

Peers

John Noviasky

PMH

PPCH

PHYSI

PHARM

PFM

Mohamed A. Khalil Egypt

Matthew B. Novitch United States

Michael Baehr Germany

Elspeth E. Shipton New Zealand

Barry J Gales United States

Johannes Strasser Switzerland

Jiseung Kang South Korea

Marie Gérardin France

Gershon Bodner United States

S Kropp Germany

Mohamed A. Khalil Egypt

John Noviasky

98 ×0.7

PMH

41 ×0.6

PPCH

93 ×1.5

PHYSI

78 ×1.3

PHARM

16 ×0.3

PFM

Citations per year, relative to John Noviasky John Noviasky (= 1×) peers Mohamed A. Khalil

Countries citing papers authored by John Noviasky

Since Specialization

Citations

This map shows the geographic impact of John Noviasky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Noviasky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Noviasky more than expected).

Fields of papers citing papers by John Noviasky

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Noviasky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Noviasky. The network helps show where John Noviasky may publish in the future.

Co-authorship network of co-authors of John Noviasky

This figure shows the co-authorship network connecting the top 25 collaborators of John Noviasky. A scholar is included among the top collaborators of John Noviasky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Noviasky. John Noviasky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Brangman, Sharon A., et al.. (2024). Improved Outcomes When Home-Dose Carbidopa-Levodopa Is Continued in the Geriatric Emergency Department in Patients With Parkinson’s Disease. The Senior Care Pharmacist. 39(7). 242–248.

McCall, Kenneth L., et al.. (2024). Utilization of Lower-Dose Cyclobenzaprine in the Older Inpatient. The Senior Care Pharmacist. 39(7). 249–258. 1 indexed citations

Noviasky, John, et al.. (2022). Efficacy and Safety of Megestrol in the Hospitalized Older Person. The Senior Care Pharmacist. 37(7). 284–292. 2 indexed citations

Noviasky, John, et al.. (2022). Aducanumab for Alzheimer's Disease: Summarized Data From EMERGE, ENGAGE, and PRIME Studies. The Senior Care Pharmacist. 37(8). 329–334. 9 indexed citations

Guharoy, Roy & John Noviasky. (2021). Executive Order on Ensuring Essential Medicines—All Bark, No Bite?. Mayo Clinic Proceedings. 96(7). 1714–1717. 1 indexed citations

Guharoy, Roy, Edward P. Krenzelok, & John Noviasky. (2020). Race Against the Pandemic: The United States and Global Health. Journal of Emergency Medicine. 60(3). 402–406. 1 indexed citations

Guharoy, Roy, John Noviasky, Ziad Haydar, Mohamad G. Fakih, & Christian Hartman. (2013). Compounding Pharmacy Conundrum. CHEST Journal. 143(4). 896–900. 14 indexed citations

Darko, William, et al.. (2010). Mixing and compatibility guide for commonly used aerosolized medications. American Journal of Health-System Pharmacy. 67(3). 227–230. 12 indexed citations

Chavez, Mary L., Eric W. Jackson, Steven L. Barriere, et al.. (2008). Pharmacists and Industry: Guidelines for Ethical Interactions. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 28(3). 410–420. 9 indexed citations

10.

Noviasky, John. (2007). Controversy and Conflict in the Treatment of Acute Decompensated Heart Failure: Limited Role for Nesiritide. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 27(5). 626–632. 3 indexed citations

11.

Noviasky, John, et al.. (2006). Clinical inquiries. Which medications can be split without compromising efficacy and safety?. PubMed. 55(8). 707–8. 16 indexed citations

12.

Lo, Vincent, et al.. (2005). Statin therapy in patients with type 2 diabetes.. PubMed. 72(5). 866–8. 1 indexed citations

13.

Noviasky, John, et al.. (2005). Seizures associated with memantine use. American Journal of Health-System Pharmacy. 62(4). 420–421. 10 indexed citations

14.

Noviasky, John, et al.. (2005). Seizures associated with memantine use. American Journal of Health-System Pharmacy. 62(4). 420–421. 12 indexed citations

15.

Guharoy, Roy, et al.. (2004). West Nile virus infection. American Journal of Health-System Pharmacy. 61(12). 1235–1241. 13 indexed citations

16.

Noviasky, John, et al.. (2003). Science or Fiction: Use of Nesiritide as a First‐Line Agent?. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 23(8). 1081–1083. 10 indexed citations

17.

Noviasky, John, et al.. (2001). The “Superiority” of Enoxaparin for Treatment of Acute Coronary Syndromes. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 21(10). 1250–1252. 1 indexed citations

18.

Noviasky, John, et al.. (2001). Second Generation Anticonvulsant Medications: Their Use in Children. The Journal of School Nursing. 17(2). 103–111. 2 indexed citations

19.

Porsteinsson, Anton P., Pierre N. Tariot, Rosemary Erb, et al.. (2001). Placebo-Controlled Study of Divalproex Sodium for Agitation in Dementia. American Journal of Geriatric Psychiatry. 9(1). 58–66. 137 indexed citations

20.

Tariot, Pierre N., Heather A. Wishart, Christopher Cox, et al.. (2000). A 12-Week, Open Trial of Donepezil Hydrochloride in Patients with Multiple Sclerosis and Associated Cognitive Impairments. Journal of Clinical Psychopharmacology. 20(3). 350–356. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact